{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:29Z","timestamp":1792788029107,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770591"],"award-info":[{"award-number":["81770591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800778"],"award-info":[{"award-number":["81800778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Medical Talents Fund of Jiangsu Province","award":["ZDRCA2016007"],"award-info":[{"award-number":["ZDRCA2016007"]}]},{"name":"Medical Innovation Team Project of Jiangsu Province","award":["CXTDA2017023"],"award-info":[{"award-number":["CXTDA2017023"]}]},{"name":"National Science and Technology Program during the Thirteenth Five-year Plan Period","award":["2017ZX10202201"],"award-info":[{"award-number":["2017ZX10202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis B virus (HBV) is a DNA virus belonging to the Hepadnaviridae family that has limited tissue and species specificity. Due to the persistence of HBV covalently closed circular DNA (cccDNA) in host cells after HBV infection, current antiviral drugs cannot eradicate HBV. Therefore, the development of an active cell culture system supporting HBV infection has become the key to studying HBV and developing effective therapeutic drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>\n                      This review summarizes the significant research achievements in HBV cell culture systems\n                      <jats:italic>in vitro<\/jats:italic>\n                      , including embryonic hepatocytes and primary hepatocytes, which support the virus infection process most similar to that in the body and various liver tumor cells. The discovery of the bile-acid pump sodium-taurocholate co-transporting polypeptide (NTCP)\u00a0as the receptor of HBV has advanced our understanding of HBV biology. Subsequently, various liver cancer cells overexpressing NTCP that support HBV infection have been established, opening a new door for studying HBV infection. The fact that induced pluripotent stem cells that differentiate into hepatocyte-like cells support HBV infection provides a novel idea for the establishment of an HBV cell culture system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Because of the host and tissue specificity of HBV, a suitable\n                      <jats:italic>in vitro<\/jats:italic>\n                      HBV infection system is critical for the study of HBV pathogenesis. Nevertheless, recent advances regarding HBV infection\n                      <jats:italic>in vitro<\/jats:italic>\n                      offer hope for better studying the biological characteristics of HBV, the pathogenesis of hepatitis B, the screening of anti-HBV drugs and the mechanism of carcinogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-021-01580-6","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:04:02Z","timestamp":1625547842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Advances in HBV infection and replication systems in vitro"],"prefix":"10.1186","volume":"18","author":[{"given":"Ruirui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anran","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0657-828X","authenticated-orcid":false,"given":"Chuanlong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"issue":"19","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/jvi.00867-09]","volume":"83","author":"S Asabe","year":"2009","unstructured":"Asabe S, Wieland SF, Chattopadhyay PK, et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol. 2009;83(19):9652\u201362. https:\/\/doi.org\/10.1128\/jvi.00867-09].","journal-title":"J Virol"},{"issue":"4","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jmv.22014","volume":"83","author":"PN Cheng","year":"2011","unstructured":"Cheng PN, Liu WC, Tsai HW, et al. Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents. J Med Virol. 2011;83(4):602\u20137. https:\/\/doi.org\/10.1002\/jmv.22014.","journal-title":"J Med Virol"},{"issue":"12","key":"1580_CR3","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal M. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut. 2015;64(12):1972\u201384. https:\/\/doi.org\/10.1136\/gutjnl-2015-309809.","journal-title":"Gut"},{"issue":"3","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jhep.2004.12.015","volume":"42","author":"F Zoulim","year":"2005","unstructured":"Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol. 2005;42(3):302\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2004.12.015.","journal-title":"J Hepatol"},{"issue":"11","key":"1580_CR5","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1128\/JVI.62.11.4136-4143.1988","volume":"62","author":"P Gripon","year":"1988","unstructured":"Gripon P, Diot C, Theze N, et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol. 1988;62(11):4136\u201343.","journal-title":"J Virol"},{"issue":"4","key":"1580_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A. 1987;84(4):1005\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1580_CR7","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1128\/JVI.62.8.2836-2844.1988","volume":"62","author":"MA Sells","year":"1988","unstructured":"Sells MA, Zelent AZ, Shvartsman M, et al. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol. 1988;62(8):2836\u201344.","journal-title":"J Virol"},{"issue":"8","key":"1580_CR8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","volume":"41","author":"SK Ladner","year":"1997","unstructured":"Ladner SK, Otto MJ, Barker CS, et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother. 1997;41(8):1715\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1128\/jvi.01123-07","volume":"81","author":"H Guo","year":"2007","unstructured":"Guo H, Jiang D, Zhou T, et al. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol. 2007;81(22):12472\u201384. https:\/\/doi.org\/10.1128\/jvi.01123-07.","journal-title":"J Virol"},{"issue":"8","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1128\/aac.00473-12","volume":"56","author":"D Cai","year":"2012","unstructured":"Cai D, Mills C, Yu W, et al. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation. Antimicrob Agents Chemother. 2012;56(8):4277\u201388. https:\/\/doi.org\/10.1128\/aac.00473-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2016.05.005","volume":"132","author":"D Cai","year":"2016","unstructured":"Cai D, Wang X, Yan R, et al. Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators. Antiviral Res. 2016;132:26\u201337. https:\/\/doi.org\/10.1016\/j.antiviral.2016.05.005.","journal-title":"Antiviral Res"},{"issue":"1","key":"1580_CR12","doi-asserted-by":"publisher","first-page":"10620","DOI":"10.1038\/s41598-017-11015-4","volume":"7","author":"M Iwamoto","year":"2017","unstructured":"Iwamoto M, Cai D, Sugiyama M, et al. Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication. Sci Rep. 2017;7(1):10620. https:\/\/doi.org\/10.1038\/s41598-017-11015-4.","journal-title":"Sci Rep"},{"issue":"11","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1128\/jvi.75.11.5108-5118.2001","volume":"75","author":"MF Sprinzl","year":"2001","unstructured":"Sprinzl MF, Oberwinkler H, Schaller H, et al. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol. 2001;75(11):5108\u201318. https:\/\/doi.org\/10.1128\/jvi.75.11.5108-5118.2001.","journal-title":"J Virol"},{"issue":"22","key":"1580_CR14","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.1073\/pnas.92.22.10099","volume":"92","author":"C Hofmann","year":"1995","unstructured":"Hofmann C, Sandig V, Jennings G, et al. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A. 1995;92(22):10099\u2013103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/0958-1669(95)80097-2","volume":"6","author":"JL Bramson","year":"1995","unstructured":"Bramson JL, Graham FL, Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol. 1995;6(5):590\u20135.","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"1580_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/hum.1993.4.4-403","volume":"4","author":"Q Li","year":"1993","unstructured":"Li Q, Kay MA, Finegold M, et al. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther. 1993;4(4):403\u20139. https:\/\/doi.org\/10.1089\/hum.1993.4.4-403.","journal-title":"Hum Gene Ther"},{"key":"1580_CR17","doi-asserted-by":"crossref","unstructured":"Delaney WEt, Miller TG, Isom HC. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (\u2212)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother 1999; 43(8): 2017\u201326","DOI":"10.1128\/AAC.43.8.2017"},{"key":"1580_CR18","doi-asserted-by":"publisher","unstructured":"Delaney WET, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 1998; 28(4): 1134-46. doi: https:\/\/doi.org\/10.1002\/hep.510280432","DOI":"10.1002\/hep.510280432"},{"issue":"16","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.1128\/JVI.76.16.8148-8160.2002","volume":"76","author":"AM Abdelhamed","year":"2002","unstructured":"Abdelhamed AM, Kelley CM, Miller TG, et al. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol. 2002;76(16):8148\u201360.","journal-title":"J Virol"},{"issue":"6","key":"1580_CR20","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1073\/pnas.93.6.2348","volume":"93","author":"FM Boyce","year":"1996","unstructured":"Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci U S A. 1996;93(6):2348\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1580_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/sj.gt.3300607","volume":"5","author":"C Hofmann","year":"1998","unstructured":"Hofmann C, Strauss M. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 1998;5(4):531\u20136. https:\/\/doi.org\/10.1038\/sj.gt.3300607.","journal-title":"Gene Ther"},{"issue":"6","key":"1580_CR22","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1073\/pnas.86.6.1875","volume":"86","author":"T Ochiya","year":"1989","unstructured":"Ochiya T, Tsurimoto T, Ueda K, et al. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Proc Natl Acad Sci U S A. 1989;86(6):1875\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3748\/wjg.v13.i7.1027","volume":"13","author":"M Lin","year":"2007","unstructured":"Lin M, Chen Q, Yang LY, et al. Hepatitis B virus infection and replication in primarily cultured human fetal hepatocytes. World J Gastroenterol. 2007;13(7):1027\u201331. https:\/\/doi.org\/10.3748\/wjg.v13.i7.1027.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1580_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1053\/jhep.2003.50448","volume":"38","author":"CA L\u00e1zaro","year":"2003","unstructured":"L\u00e1zaro CA, Croager EJ, Mitchell C, et al. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology. 2003;38(5):1095\u2013106. https:\/\/doi.org\/10.1053\/jhep.2003.50448.","journal-title":"Hepatology"},{"key":"1580_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jviromet.2013.10.010","volume":"195","author":"M Zhou","year":"2014","unstructured":"Zhou M, Zhao F, Li J, et al. Long-term maintenance of human fetal hepatocytes and prolonged susceptibility to HBV infection by co-culture with non-parenchymal cells. J Virol Methods. 2014;195:185\u201393. https:\/\/doi.org\/10.1016\/j.jviromet.2013.10.010.","journal-title":"J Virol Methods"},{"issue":"6","key":"1580_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0168-8278(03)00120-X","volume":"38","author":"H Schulze-Bergkamen","year":"2003","unstructured":"Schulze-Bergkamen H, Untergasser A, Dax A, et al. Primary human hepatocytes: a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol. 2003;38(6):736\u201344.","journal-title":"J Hepatol"},{"key":"1580_CR27","doi-asserted-by":"crossref","unstructured":"Rijntjes PJ, Moshage HJ, Van Gemert PJ, et al. Cryopreservation of adult human hepatocytes. The influence of deep freezing storage on the viability, cell seeding, survival, fine structures and albumin synthesis in primary cultures. J Hepatol 1986; 3(1): 7-18","DOI":"10.1016\/S0168-8278(86)80140-4"},{"issue":"3","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/0016-5085(94)90700-5","volume":"106","author":"PR Galle","year":"1994","unstructured":"Galle PR, Hagelstein J, Kommerell B, et al. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology. 1994;106(3):664\u201373. https:\/\/doi.org\/10.1016\/0016-5085(94)90700-5.","journal-title":"Gastroenterology"},{"issue":"1","key":"1580_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/jsre.2002.6446","volume":"106","author":"N Katsura","year":"2002","unstructured":"Katsura N, Ikai I, Mitaka T, et al. Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions. J Surg Res. 2002;106(1):115\u201323.","journal-title":"J Surg Res"},{"issue":"2","key":"1580_CR30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1006\/viro.1993.1069","volume":"192","author":"P Gripon","year":"1993","unstructured":"Gripon P, Diot C, Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology. 1993;192(2):534\u201340. https:\/\/doi.org\/10.1006\/viro.1993.1069.","journal-title":"Virology"},{"issue":"5","key":"1580_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ajpath.2015.01.028","volume":"185","author":"Y Ishida","year":"2015","unstructured":"Ishida Y, Yamasaki C, Yanagi A, et al. Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. Am J Pathol. 2015;185(5):1275\u201385. https:\/\/doi.org\/10.1016\/j.ajpath.2015.01.028.","journal-title":"Am J Pathol"},{"issue":"1","key":"1580_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.112.195750","volume":"343","author":"M Ulvestad","year":"2012","unstructured":"Ulvestad M, Darnell M, Molden E, et al. Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system. J Pharmacol Exp Ther. 2012;343(1):145\u201356. https:\/\/doi.org\/10.1124\/jpet.112.195750.","journal-title":"J Pharmacol Exp Ther"},{"issue":"14","key":"1580_CR33","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1096\/fasebj.13.14.1883","volume":"13","author":"SN Bhatia","year":"1999","unstructured":"Bhatia SN, Balis UJ, Yarmush ML, et al. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. Faseb J. 1999;13(14):1883\u2013900.","journal-title":"Faseb J"},{"issue":"6","key":"1580_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1084952102001301","volume":"13","author":"R Malik","year":"2002","unstructured":"Malik R, Selden C, Hodgson H. The role of non-parenchymal cells in liver growth. Semin Cell Dev Biol. 2002;13(6):425\u201331.","journal-title":"Semin Cell Dev Biol"},{"issue":"3\u20134","key":"1580_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/ten.TEA.2010.0033","volume":"17","author":"J Kasuya","year":"2011","unstructured":"Kasuya J, Sudo R, Mitaka T, et al. Hepatic stellate cell-mediated three-dimensional hepatocyte and endothelial cell triculture model. Tissue Eng Part A. 2011;17(3\u20134):361\u201370. https:\/\/doi.org\/10.1089\/ten.TEA.2010.0033.","journal-title":"Tissue Eng Part A"},{"issue":"1","key":"1580_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41422-018-0103-x","volume":"29","author":"GB Fu","year":"2019","unstructured":"Fu GB, Huang WJ, Zeng M, et al. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Res. 2019;29(1):8\u201322. https:\/\/doi.org\/10.1038\/s41422-018-0103-x.","journal-title":"Cell Res"},{"issue":"6","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","volume":"23","author":"K Zhang","year":"2018","unstructured":"Zhang K, Zhang L, Liu W, et al. In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell. 2018;23(6):806-819.e4. https:\/\/doi.org\/10.1016\/j.stem.2018.10.018.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1580_CR38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cell.2018.11.012","volume":"175","author":"WC Peng","year":"2018","unstructured":"Peng WC, Logan CY, Fish M, et al. Inflammatory cytokine TNFalpha promotes the long-term expansion of primary hepatocytes in 3D culture. Cell. 2018;175(6):1607\u201319. https:\/\/doi.org\/10.1016\/j.cell.2018.11.012.","journal-title":"Cell"},{"issue":"6","key":"1580_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu H, Gehart H, Artegiani B, et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell. 2018;175(6):1591\u2013606. https:\/\/doi.org\/10.1016\/j.cell.2018.11.013.","journal-title":"Cell"},{"issue":"4","key":"1580_CR40","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.24760","volume":"55","author":"RM Tost\u00f5es","year":"2012","unstructured":"Tost\u00f5es RM, Leite SB, Serra M, et al. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology. 2012;55(4):1227\u201336. https:\/\/doi.org\/10.1002\/hep.24760.","journal-title":"Hepatology"},{"issue":"7","key":"1580_CR41","doi-asserted-by":"publisher","first-page":"e1800347","DOI":"10.1002\/biot.201800347","volume":"14","author":"VM Lauschke","year":"2019","unstructured":"Lauschke VM, Shafagh RZ, Hendriks DFG, et al. 3D primary hepatocyte culture systems for analyses of liver diseases, drug metabolism, and toxicity: emerging culture paradigms and applications. Biotechnol J. 2019;14(7):e1800347. https:\/\/doi.org\/10.1002\/biot.201800347.","journal-title":"Biotechnol J"},{"issue":"6","key":"1580_CR42","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1096\/fj.201601375R","volume":"31","author":"SU Vorrink","year":"2017","unstructured":"Vorrink SU, Ullah S, Schmidt S, et al. Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. Faseb J. 2017;31(6):2696\u2013708. https:\/\/doi.org\/10.1096\/fj.201601375R.","journal-title":"Faseb J"},{"issue":"9","key":"1580_CR43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3109\/00498254.2012.669080","volume":"42","author":"AK Sohlenius-Sternbeck","year":"2012","unstructured":"Sohlenius-Sternbeck AK, Jones C, Ferguson D, et al. Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes. Xenobiotica. 2012;42(9):841\u201353. https:\/\/doi.org\/10.3109\/00498254.2012.669080.","journal-title":"Xenobiotica"},{"issue":"3","key":"1580_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1124\/dmd.117.078949","volume":"46","author":"FL Wood","year":"2018","unstructured":"Wood FL, Houston JB, Hallifax D. Importance of the unstirred water layer and hepatocyte membrane integrity in vitro for quantification of intrinsic metabolic clearance. Drug Metab Dispos. 2018;46(3):268\u201378. https:\/\/doi.org\/10.1124\/dmd.117.078949.","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"1580_CR45","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1124\/dmd.115.066431","volume":"43","author":"JM Hutzler","year":"2015","unstructured":"Hutzler JM, Ring BJ, Anderson SR. Low-turnover drug molecules: a current challenge for drug metabolism scientists. Drug Metab Dispos. 2015;43(12):1917\u201328. https:\/\/doi.org\/10.1124\/dmd.115.066431.","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"1580_CR46","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1039\/c4lc00071d","volume":"14","author":"M Hegde","year":"2014","unstructured":"Hegde M, Jindal R, Bhushan A, et al. Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform. Lab Chip. 2014;14(12):2033\u20139. https:\/\/doi.org\/10.1039\/c4lc00071d.","journal-title":"Lab Chip"},{"issue":"9","key":"1580_CR47","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1039\/b926846d","volume":"10","author":"R Fernandes","year":"2010","unstructured":"Fernandes R, Luo X, Tsao CY, et al. Biological nanofactories facilitate spatially selective capture and manipulation of quorum sensing bacteria in a bioMEMS device. Lab Chip. 2010;10(9):1128\u201334. https:\/\/doi.org\/10.1039\/b926846d.","journal-title":"Lab Chip"},{"issue":"1","key":"1580_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.taap.2013.11.022","volume":"275","author":"FA Atienzar","year":"2014","unstructured":"Atienzar FA, Novik EI, Gerets HH, et al. Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans. Toxicol Appl Pharmacol. 2014;275(1):44\u201361. https:\/\/doi.org\/10.1016\/j.taap.2013.11.022.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"1580_CR49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1124\/dmd.115.067769","volume":"44","author":"B Bonn","year":"2016","unstructured":"Bonn B, Svanberg P, Janefeldt A, et al. Determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: comparison of a primary hepatocyte\/stromal cell co-culture with plated primary hepatocytes and HepaRG. Drug Metab Dispos. 2016;44(4):527\u201333. https:\/\/doi.org\/10.1124\/dmd.115.067769.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1580_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41467-017-00200-8","volume":"8","author":"BY Winer","year":"2017","unstructured":"Winer BY, Huang TS, Pludwinski E, et al. Long-term hepatitis B infection in a scalable hepatic co-culture system. Nat Commun. 2017;8(1):125. https:\/\/doi.org\/10.1038\/s41467-017-00200-8.","journal-title":"Nat Commun"},{"issue":"1","key":"1580_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.510240101","volume":"24","author":"E Walter","year":"1996","unstructured":"Walter E, Keist R, Niederost B, et al. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology. 1996;24(1):1\u20135. https:\/\/doi.org\/10.1002\/hep.510240101.","journal-title":"Hepatology"},{"issue":"17","key":"1580_CR52","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1128\/JVI.77.17.9511-9521.2003","volume":"77","author":"D Glebe","year":"2003","unstructured":"Glebe D, Aliakbari M, Krass P, et al. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol. 2003;77(17):9511\u201321.","journal-title":"J Virol"},{"key":"1580_CR53","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1:e00049. https:\/\/doi.org\/10.7554\/eLife.00049.","journal-title":"Elife"},{"key":"1580_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.virol.2013.10.016","volume":"448","author":"G Xu","year":"2014","unstructured":"Xu G, Gao Z, He W, et al. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture. Virology. 2014;448:247\u201354. https:\/\/doi.org\/10.1016\/j.virol.2013.10.016.","journal-title":"Virology"},{"issue":"24","key":"1580_CR55","doi-asserted-by":"publisher","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A. 2002;99(24):15655\u201360. https:\/\/doi.org\/10.1073\/pnas.232137699.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1580_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/hep.24707","volume":"55","author":"A Schulze","year":"2012","unstructured":"Schulze A, Mills K, Weiss TS, et al. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology. 2012;55(2):373\u201383. https:\/\/doi.org\/10.1002\/hep.24707.","journal-title":"Hepatology"},{"issue":"3","key":"1580_CR57","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1128\/jvi.79.3.1613-1622.2005","volume":"79","author":"P Gripon","year":"2005","unstructured":"Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol. 2005;79(3):1613\u201322. https:\/\/doi.org\/10.1128\/jvi.79.3.1613-1622.2005.","journal-title":"J Virol"},{"key":"1580_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-60761-688-7_13","volume":"640","author":"MJ Marion","year":"2010","unstructured":"Marion MJ, Hantz O, Durantel D. The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies. Methods Mol Biol. 2010;640:261\u201372. https:\/\/doi.org\/10.1007\/978-1-60761-688-7_13.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1580_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.105.006759","volume":"34","author":"C Aninat","year":"2006","unstructured":"Aninat C, Piton A, Glaise D, et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos. 2006;34(1):75\u201383. https:\/\/doi.org\/10.1124\/dmd.105.006759.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"1580_CR60","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019.","journal-title":"Cell"},{"issue":"5858","key":"1580_CR61","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320. https:\/\/doi.org\/10.1126\/science.1151526.","journal-title":"Science"},{"issue":"1","key":"1580_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.23354","volume":"51","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010;51(1):297\u2013305. https:\/\/doi.org\/10.1002\/hep.23354.","journal-title":"Hepatology"},{"key":"1580_CR63","doi-asserted-by":"publisher","first-page":"29358","DOI":"10.1038\/srep29358","volume":"6","author":"S Kaneko","year":"2016","unstructured":"Kaneko S, Kakinuma S, Asahina Y, et al. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep. 2016;6:29358. https:\/\/doi.org\/10.1038\/srep29358.","journal-title":"Sci Rep"},{"key":"1580_CR64","doi-asserted-by":"publisher","first-page":"45698","DOI":"10.1038\/srep45698","volume":"7","author":"F Sakurai","year":"2017","unstructured":"Sakurai F, Mitani S, Yamamoto T, et al. Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection. Sci Rep. 2017;7:45698. https:\/\/doi.org\/10.1038\/srep45698.","journal-title":"Sci Rep"},{"issue":"3","key":"1580_CR65","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","volume":"66","author":"Y Xia","year":"2017","unstructured":"Xia Y, Carpentier A, Cheng X, et al. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. J Hepatol. 2017;66(3):494\u2013503. https:\/\/doi.org\/10.1016\/j.jhep.2016.10.009.","journal-title":"J Hepatol"},{"key":"1580_CR66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","volume":"35","author":"YZ Nie","year":"2018","unstructured":"Nie YZ, Zheng YW, Miyakawa K, et al. Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells. EBioMedicine. 2018;35:114\u201323. https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.014.","journal-title":"EBioMedicine"},{"issue":"6","key":"1580_CR67","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/hep.21896","volume":"46","author":"A Schulze","year":"2007","unstructured":"Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759\u201368. https:\/\/doi.org\/10.1002\/hep.21896.","journal-title":"Hepatology"},{"issue":"15","key":"1580_CR68","doi-asserted-by":"publisher","first-page":"9786","DOI":"10.1128\/jvi.79.15.9786-9798.2005","volume":"79","author":"A Barrera","year":"2005","unstructured":"Barrera A, Guerra B, Notvall L, et al. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol. 2005;79(15):9786\u201398. https:\/\/doi.org\/10.1128\/jvi.79.15.9786-9798.2005.","journal-title":"J Virol"},{"issue":"1","key":"1580_CR69","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","volume":"129","author":"D Glebe","year":"2005","unstructured":"Glebe D, Urban S, Knoop EV, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology. 2005;129(1):234\u201345.","journal-title":"Gastroenterology"},{"issue":"4","key":"1580_CR70","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/hep.21112","volume":"43","author":"M Engelke","year":"2006","unstructured":"Engelke M, Mills K, Seitz S, et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology. 2006;43(4):750\u201360. https:\/\/doi.org\/10.1002\/hep.21112.","journal-title":"Hepatology"},{"issue":"4","key":"1580_CR71","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1128\/JVI.76.4.1986-1990.2002","volume":"76","author":"S Urban","year":"2002","unstructured":"Urban S, Gripon P. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J Virol. 2002;76(4):1986\u201390.","journal-title":"J Virol"},{"issue":"4","key":"1580_CR72","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","volume":"146","author":"Y Ni","year":"2014","unstructured":"Ni Y, Lempp FA, Mehrle S, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014;146(4):1070\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2013.12.024.","journal-title":"Gastroenterology"},{"issue":"6","key":"1580_CR73","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/0016-5085(94)90821-4","volume":"107","author":"B Stieger","year":"1994","unstructured":"Stieger B, Hagenbuch B, Landmann L, et al. In situ localization of the hepatocytic Na+\/Taurocholate cotransporting polypeptide in rat liver. Gastroenterology. 1994;107(6):1781\u20137.","journal-title":"Gastroenterology"},{"key":"1580_CR74","doi-asserted-by":"publisher","unstructured":"Claro da Silva T, Polli JE, Swaan PW. The solute carrier family 10 (SLC10): beyond bile acid transport. Mol Aspects Med 2013; 34(2\u20133): 252-69. DOI: https:\/\/doi.org\/10.1016\/j.mam.2012.07.004","DOI":"10.1016\/j.mam.2012.07.004"},{"key":"1580_CR75","doi-asserted-by":"publisher","unstructured":"Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol 2011: 205\u2013259 DOI: https:\/\/doi.org\/10.1007\/978-3-642-14541-4_5","DOI":"10.1007\/978-3-642-14541-4_5"},{"issue":"14","key":"1580_CR76","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1128\/jvi.03540-12","volume":"87","author":"H Yan","year":"2013","unstructured":"Yan H, Peng B, He W, et al. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol. 2013;87(14):7977\u201391. https:\/\/doi.org\/10.1128\/jvi.03540-12.","journal-title":"J Virol"},{"issue":"5","key":"1580_CR77","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/hep.26982","volume":"59","author":"K Watashi","year":"2014","unstructured":"Watashi K, Sluder A, Daito T, et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology. 2014;59(5):1726\u201337. https:\/\/doi.org\/10.1002\/hep.26982.","journal-title":"Hepatology"},{"issue":"4","key":"1580_CR78","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","volume":"60","author":"S Nkongolo","year":"2014","unstructured":"Nkongolo S, Ni Y, Lempp FA, et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. J Hepatol. 2014;60(4):723\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2013.11.022.","journal-title":"J Hepatol"},{"issue":"9","key":"1580_CR79","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1074\/jbc.M114.602540","volume":"290","author":"S Tsukuda","year":"2015","unstructured":"Tsukuda S, Watashi K, Iwamoto M, et al. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression. J Biol Chem. 2015;290(9):5673\u201384. https:\/\/doi.org\/10.1074\/jbc.M114.602540.","journal-title":"J Biol Chem"},{"issue":"6","key":"1580_CR80","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1053\/j.gastro.2018.01.044","volume":"154","author":"P Mutz","year":"2018","unstructured":"Mutz P, Metz P, Lempp FA, et al. HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon. Gastroenterology. 2018;154(6):1791-1804.e22. https:\/\/doi.org\/10.1053\/j.gastro.2018.01.044.","journal-title":"Gastroenterology"},{"issue":"2","key":"1580_CR81","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3390\/ijms15022892","volume":"15","author":"K Watashi","year":"2014","unstructured":"Watashi K, Urban S, Li W, et al. NTCP and beyond: opening the door to unveil hepatitis B virus entry. Int J Mol Sci. 2014;15(2):2892\u2013905. https:\/\/doi.org\/10.3390\/ijms15022892.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1580_CR82","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbrc.2018.04.187","volume":"501","author":"W Saso","year":"2018","unstructured":"Saso W, Tsukuda S, Ohashi H, et al. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction. Biochem Biophys Res Commun. 2018;501(2):374\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.187.","journal-title":"Biochem Biophys Res Commun"},{"issue":"34","key":"1580_CR83","doi-asserted-by":"publisher","first-page":"23681","DOI":"10.18632\/oncotarget.25348","volume":"9","author":"K Miyakawa","year":"2018","unstructured":"Miyakawa K, Matsunaga S, Yamaoka Y, et al. Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide. Oncotarget. 2018;9(34):23681\u201394. https:\/\/doi.org\/10.18632\/oncotarget.25348.","journal-title":"Oncotarget"},{"issue":"1","key":"1580_CR84","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1038\/s41598-018-20987-w","volume":"8","author":"M Kaneko","year":"2018","unstructured":"Kaneko M, Futamura Y, Tsukuda S, et al. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide. Sci Rep. 2018;8(1):2769. https:\/\/doi.org\/10.1038\/s41598-018-20987-w.","journal-title":"Sci Rep"},{"issue":"1","key":"1580_CR85","doi-asserted-by":"publisher","first-page":"14461","DOI":"10.1038\/s41598-017-14573-9","volume":"7","author":"G Choijilsuren","year":"2017","unstructured":"Choijilsuren G, Jhou RS, Chou SF, et al. Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus. Sci Rep. 2017;7(1):14461. https:\/\/doi.org\/10.1038\/s41598-017-14573-9.","journal-title":"Sci Rep"},{"issue":"2","key":"1580_CR86","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jhep.2019.04.010","volume":"71","author":"A K\u00f6nig","year":"2019","unstructured":"K\u00f6nig A, Yang J, Jo E, et al. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. J Hepatol. 2019;71(2):289\u2013300. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.010.","journal-title":"J Hepatol"},{"issue":"1","key":"1580_CR87","doi-asserted-by":"publisher","first-page":"16616","DOI":"10.1038\/s41598-017-16882-5","volume":"7","author":"E Michailidis","year":"2017","unstructured":"Michailidis E, Pabon J, Xiang K, et al. A robust cell culture system supporting the complete life cycle of hepatitis B virus. Sci Rep. 2017;7(1):16616. https:\/\/doi.org\/10.1038\/s41598-017-16882-5.","journal-title":"Sci Rep"},{"issue":"17","key":"1580_CR88","doi-asserted-by":"publisher","first-page":"16739","DOI":"10.1074\/jbc.M414139200","volume":"280","author":"K Li","year":"2005","unstructured":"Li K, Chen Z, Kato N, et al. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005;280(17):16739\u201347. https:\/\/doi.org\/10.1074\/jbc.M414139200.","journal-title":"J Biol Chem"},{"issue":"1","key":"1580_CR89","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0167-4889(99)00089-0","volume":"1451","author":"M Tnani","year":"1999","unstructured":"Tnani M, Bayard BA. Evidence for IRF-1-dependent gene expression deficiency in interferon unresponsive HepG2 cells. Biochim Biophys Acta. 1999;1451(1):59\u201372.","journal-title":"Biochim Biophys Acta"},{"key":"1580_CR90","doi-asserted-by":"publisher","unstructured":"Li GQ, Xu WZ, Wang JX, et al. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells. World J Gastroenterol 2007; 13(16): 2324\u20137 DOI: https:\/\/doi.org\/10.3748\/wjg.v13.i16.2324","DOI":"10.3748\/wjg.v13.i16.2324"},{"issue":"2","key":"1580_CR91","first-page":"E71","volume":"65","author":"P Indrasetiawan","year":"2019","unstructured":"Indrasetiawan P, Aoki-Utsubo C, Hanafi M, et al. Antiviral activity of cananga odorata against hepatitis B virus. Kobe J Med Sci. 2019;65(2):E71-e79.","journal-title":"Kobe J Med Sci"},{"issue":"21","key":"1580_CR92","doi-asserted-by":"publisher","first-page":"13825","DOI":"10.1073\/pnas.202398599","volume":"99","author":"PL Yang","year":"2002","unstructured":"Yang PL, Althage A, Chung J, et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A. 2002;99(21):13825\u201330. https:\/\/doi.org\/10.1073\/pnas.202398599.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1580_CR93","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.23602","volume":"51","author":"J Lucifora","year":"2010","unstructured":"Lucifora J, Vincent IE, Berthillon P, et al. Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model. Hepatology. 2010;51(6):1954\u201360. https:\/\/doi.org\/10.1002\/hep.23602.","journal-title":"Hepatology"},{"issue":"5","key":"1580_CR94","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3892\/mmr.2012.1029","volume":"6","author":"F Wang","year":"2012","unstructured":"Wang F, Zhang X, Zhang J, et al. Effect of fibronectin on HBV infection in primary human fetal hepatocytes in vitro. Mol Med Rep. 2012;6(5):1145\u20139. https:\/\/doi.org\/10.3892\/mmr.2012.1029.","journal-title":"Mol Med Rep"},{"issue":"2","key":"1580_CR95","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/s0022-3549(15)00192-6","volume":"105","author":"KA Rose","year":"2016","unstructured":"Rose KA, Holman NS, Green AM, et al. Co-culture of hepatocytes and Kupffer Cells as an in vitro model of inflammation and drug-induced hepatotoxicity. J Pharm Sci. 2016;105(2):950\u201364. https:\/\/doi.org\/10.1016\/s0022-3549(15)00192-6.","journal-title":"J Pharm Sci"},{"issue":"2","key":"1580_CR96","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.20553","volume":"41","author":"TF Baumert","year":"2005","unstructured":"Baumert TF, Yang C, Sch\u00fcrmann P, et al. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. Hepatology. 2005;41(2):247\u201356. https:\/\/doi.org\/10.1002\/hep.20553.","journal-title":"Hepatology"},{"issue":"33","key":"1580_CR97","doi-asserted-by":"publisher","first-page":"12193","DOI":"10.1073\/pnas.1412631111","volume":"111","author":"A Shlomai","year":"2014","unstructured":"Shlomai A, Schwartz RE, Ramanan V, et al. Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc Natl Acad Sci U S A. 2014;111(33):12193\u20138. https:\/\/doi.org\/10.1073\/pnas.1412631111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1580_CR98","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00204-016-1756-1","volume":"90","author":"MJ G\u00f3mez-Lech\u00f3n","year":"2016","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Tolosa L. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Arch Toxicol. 2016;90(9):2049\u201361. https:\/\/doi.org\/10.1007\/s00204-016-1756-1.","journal-title":"Arch Toxicol"},{"issue":"3","key":"1580_CR99","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","volume":"443","author":"M Iwamoto","year":"2014","unstructured":"Iwamoto M, Watashi K, Tsukuda S, et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun. 2014;443(3):808\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.052.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-021-01580-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:13:52Z","timestamp":1625548432000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01580-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}